DS Stage III Plasma Cell Myeloma

13 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch DS Stage III Plasma Cell Myeloma

Record	Firm	Date
Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant (NCT01899326)	Albert Einstein College of Medicine	2013-09-01
Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT01936090)	Mayo Clinic	2013-08-01
Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT01842308)	Mayo Clinic	2013-06-04
NK Cells in Cord Blood Transplantation (NCT01619761)	M.D. Anderson Cancer Center	2013-05-03
S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma (NCT01668719)	SWOG Cancer Research Network	2012-11-01
Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT01605032)	Albert Einstein College of Medicine	2012-02-01
Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma (NCT01330173)	National Cancer Institute (NCI)	2010-12-01
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01028716)	Fred Hutchinson Cancer Center	2010-05-19
Bortezomib and Vorinostat in Treating Patients With Multiple Myeloma Who Have Undergone Autologous Stem Cell Transplant (NCT00839956)	Fred Hutchinson Cancer Center	2009-02-01
Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma (NCT00445692)	Fred Hutchinson Cancer Center	2007-01-10
Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma (NCT00088855)	National Cancer Institute (NCI)	2004-06-15
FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00066638)	National Cancer Institute (NCI)	2003-06-01

Track DS Stage III Plasma Cell Myeloma automatically

Every clearance here is in the API, with alerts when new ones post.